Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Double-blind Study AGLU02704	STARTED	Alglucosidase Alfa/Alglucosidase Alfa	60
Double-blind Study AGLU02704	STARTED	Placebo/Alglucosidase Alfa	30
Double-blind Study AGLU02704	COMPLETED	Alglucosidase Alfa/Alglucosidase Alfa	55
Double-blind Study AGLU02704	COMPLETED	Placebo/Alglucosidase Alfa	26
Double-blind Study AGLU02704	NOT COMPLETED	Alglucosidase Alfa/Alglucosidase Alfa	5
Double-blind Study AGLU02704	NOT COMPLETED	Placebo/Alglucosidase Alfa	4
Extension Study AGLU03206	STARTED	Alglucosidase Alfa/Alglucosidase Alfa	55
Extension Study AGLU03206	STARTED	Placebo/Alglucosidase Alfa	26
Extension Study AGLU03206	COMPLETED	Alglucosidase Alfa/Alglucosidase Alfa	55
Extension Study AGLU03206	COMPLETED	Placebo/Alglucosidase Alfa	26
Extension Study AGLU03206	NOT COMPLETED	Alglucosidase Alfa/Alglucosidase Alfa	0
Extension Study AGLU03206	NOT COMPLETED	Placebo/Alglucosidase Alfa	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00455195/flow